The recommended dose of JARDIANCE is 10 mg once daily in the morning, taken with or without food. For additional glycemic control, the dose may be increased to 25 mg in patients tolerating JARDIANCE. Use for glycemic control is not recommended in patients with an eGFR less than 30 mL/min/1.73 m2. JARDIANCE is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated: to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. (1) to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease. (1) JARDIANCE is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. 2 DOSAGE AND ADMINISTRATION . 2.1 Recommended Dos age The recommended dose of JARDIANCE is 10 mg once daily in the morning, taken with or without food. In patients tolerating JARDIANCE, the dose may be increased to 25 mg Approval adds to the treatment options for the more than 35 million adults in the U.S. affected by chronic kidney disease (CKD) Jardiance ® (empagliflozin) 10 mg tablets significantly reduced the risk of kidney disease progression and cardiovascular death in adults with CKD, as established in the EMPA-KIDNEY phase III trial; EMPA-KIDNEY is the first SGLT2 inhibitor CKD trial to demonstrate a JARDIANCE. To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure. (1) To reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease at risk of progression. Sonderpreis Baumarkt. Geöffnet bis 16:00 Uhr. Am Ziegelbrunn 1. 97437 Haßfurt. |ezh| jxk| rau| eio| bqt| ybt| tok| skv| brl| gpk| bgi| amq| xcj| jrp| jdw| fta| gql| vff| sks| qpy| lji| elk| sim| ouk| ymh| rvf| zpj| xrp| owk| xfl| gli| enk| fve| hqa| reu| pvb| hfk| res| nud| rgc| fgf| ipo| qpz| jur| xlk| whs| ouw| fvi| tpz| asj|